Artificial Pancreas helps people with diabetes, primarily type 1, automatically and continuously control their blood glucose level by providing the substitute endocrine functionality of a healthy pancreas.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Artificial Pancreas under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Artificial Pancreas and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Artificial Pancreas under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Admetsys Corp
- Advanced Biosensors-Ohio LLC
- AiTA Bio Inc
- Beta Bionics Inc
- Beta-O2 Technologies Ltd
- Bigfoot Biomedical Inc
- BioTex Inc
- Captix Biomedical Pty Ltd
- Cerco Medical LLC
- Children's Hospital of Philadelphia
- Converge Biotech Inc.
- Covalor Medical
- LLC
- De Montfort University
- Debiotech SA
- Defymed SAS
- Diabeloop SA
- EOFlow Co Ltd
- Giner Inc
- Harvard John A Paulson School of Engineering and Applied Sciences
- Healios Inc
- Humacyte Inc
- Ideal Medical Technologies Inc
- Imperial College London
- Indian Institute of Science
- Inreda Diabetic BV
- Joslin Diabetes Center
- Kailian Medical Technology Co Ltd
- Kencak LLC
- McGill University
- Medtronic Inc
- Medtronic MiniMed Inc
- MicroTech Medical Co Ltd
- Miromatrix Medical Inc
- Modular Medical Inc
- Pacific Diabetes Technologies Inc
- Pancreum
- LLC
- PharmaCyte Biotech Inc
- Polytechnic University of Valencia
- Rensselaer Polytechnic Institute
- Senseonics Holdings Inc
- Shenzhen Huayuan Regenerative Medicine Co Ltd
- Stanford University
- Tandem Diabetes Care Inc
- TecMed Inc
- TypeZero Technologies LLC
- U-Needle BV
- Universidad Autonoma de Madrid
- University of California San Francisco
- University of California Santa Barbara
- University of Cambridge
- University of Florida
- University of Minnesota
- University of Newcastle
- University of Pennsylvania
- University of Queensland
- WaveForm Technologies Inc
- Xeris Biopharma Holdings Inc
- Yale University
- Ypsomed Holding AG